Publication | Closed Access

Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease

Intervertebral DiscCervical CancerCervical HealthMulticenter FoodGynecologyOutcomes ResearchSpinal FusionSurgerySpine SurgeryMedicineOrthopaedic SurgeryCervical Spine